We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 36 results
  1. Modern Diagnostic Tools for Rapid Detection of Multidrug Resistance

    The emergence of multidrug resistance (MDR) presents a serious threat to human health throughout the world. It has become a major obstacle in...
    Nimisha Tehri, Saurabh Kadyan, ... Amit Vashishth in Emerging Modalities in Mitigation of Antimicrobial Resistance
    Chapter 2022
  2. Non-commercial phenotypic assays for the detection of Mycobacterium tuberculosis drug resistance: a systematic review

    Several rapid non-commercial culture-based methods and assays for drug susceptibility testing (DST) of Mycobacterium tuberculosis have emerged over...

    Irina Kontsevaya, Jim Werngren, ... Vladyslav Nikolayevskyy in European Journal of Clinical Microbiology & Infectious Diseases
    Article 30 October 2019
  3. Tuberculosis: current scenario, drug targets, and future prospects

    Globally recognized genetic modification with time has supported the emergence of versatile and novel featured organisms in nature, some of which can...

    Priyanka Bose, Amit K. Harit, ... Sushil K. Kashaw in Medicinal Chemistry Research
    Article 20 January 2021
  4. Pediatric Tuberculosis: Current Evidence for Laboratory Diagnosis

    As children develop paucibacillary forms of tuberculosis (TB), bacteriological tests usually are negative. This chapter describes aspects of the...
    Christiane Mello Schmidt, Claudete Aparecida Araújo Cardoso, ... Clemax Couto Sant’Anna in Tuberculosis
    Chapter 2023
  5. Affinity of Mycobacterium tuberculosis strains for M059K microglial cells after migration through A549 alveolar epithelium

    Tuberculosis (TB) remains a major threat worldwide while central nervous system TB (CNS-TB) is one of the most severe forms of extrapulmonary TB....

    Article 09 April 2021
  6. Drug-Resistant Tuberculosis and HIV

    Multidrug-resistant (MDR) and extensively drug-resistant (XDR) TB are associated with substantially worse outcomes than drug-susceptible...
    Sara C. Auld, Neel R. Gandhi, James C. M. Brust in HIV and Tuberculosis
    Chapter 2019
  7. Antimycobacterial Drugs

    The Mycobacterium tuberculosis complex (MTBC)—including, the M. tuberculosis and seven other closely-related species (like M. bovis)—are the...
    Chapter 2021
  8. Nomogram to predict multidrug-resistant tuberculosis

    Background

    Multidrug-resistant tuberculosis (MDR-TB) is burgeoning globally, and has been a serious challenge in TB management. Clinically, the...

    Article Open access 06 June 2020
  9. Of tuberculosis and non-tuberculous mycobacterial infections – a comparative analysis of epidemiology, diagnosis and treatment

    Pulmonary diseases due to mycobacteria cause significant morbidity and mortality to human health. In addition to tuberculosis (TB), caused by Mycobacte...

    Radha Gopalaswamy, Sivakumar Shanmugam, ... Selvakumar Subbian in Journal of Biomedical Science
    Article Open access 17 June 2020
  10. The Challenge of Drug-Resistant Tuberculosis: An Update

    Tuberculosis (TB) is one of the leading causes of death from a single infectious agent, and millions of people fall sick due to this disease every...
    Chanchal Kumar, Kamal Shrivastava, ... Mandira Varma-Basil in Pathogenicity and Drug Resistance of Human Pathogens
    Chapter 2019
  11. Assessment of CD27 expression on T-cells as a diagnostic and therapeutic tool for patients with smear-negative pulmonary tuberculosis

    Background

    There is a global focus on illness diagnosis in smear-negative and latent tuberculosis infectious populations (SN-TB and LTBI). CD27 has...

    Feifan Xu, Haiyun Zhang, ... Yongwei Qin in BMC Immunology
    Article Open access 27 June 2021
  12. Lipocalin 2—not only a biomarker: a study of current literature and systematic findings of ongoing clinical trials

    Lipocalin 2 (Lcn2), also known as neutrophil gelatinase–associated lipocalin, is an innate immune protein encoded by the LCN2 gene. In this study,...

    Sumaira Asaf, Fazeela Maqsood, ... Ivan Cherrez Ojeda in Immunologic Research
    Article 19 December 2022
  13. TB Diagnostics: Journey from Smear Microscopy to Whole Genome Sequencing

    Tuberculosis is not just a basic clinical and general issue of the whole world. It has attracted worldwide attention of the entire scientific...
    Chapter 2019
  14. Gastrointestinal and Peritoneal Tuberculosis

    Abdominal tuberculosis may affect the gastrointestinal tract, the peritoneum, intra-abdominal lymph nodes and the solid abdominal viscera. This...
    Sophia De Saram, Jon S. Friedland in Extrapulmonary Tuberculosis
    Chapter 2019
  15. Genome-wide analysis of multi- and extensively drug-resistant Mycobacterium tuberculosis

    To characterize the genetic determinants of resistance to antituberculosis drugs, we performed a genome-wide association study (GWAS) of 6,465 Mycobact...

    Francesc Coll, Jody Phelan, ... Taane G. Clark in Nature Genetics
    Article 22 January 2018
  16. Drug-Resistant Tuberculosis

    The incidence of drug-resistant tuberculosis (TB), particularly multidrug-resistant TB and extensively drug-resistant TB, is increasing and is a...
    Lili Liang, Yun Ma, ... Yamin Lv in Drug Resistance in Bacteria, Fungi, Malaria, and Cancer
    Chapter 2017
  17. Evaluation of Mycotube, a modified version of Lowenstein–Jensen (LJ) medium, for efficient recovery of Mycobacterium tuberculosis (MTB)

    Timely diagnosis of tuberculosis (TB), caused by Mycobacterium tuberculosis (MTB), is only achieved for ~58% cases. An improved, accurate, time- and...

    R. Nambiar, S. Chatellier, ... C. Rodrigues in European Journal of Clinical Microbiology & Infectious Diseases
    Article 06 July 2017
  18. General and advanced diagnostic tools to detect Mycobacterium tuberculosis and their drug susceptibility: a review

    The global control of tuberculosis remains a great challenge from the standpoint of diagnosis, detection of drug resistance, and treatment, because...

    Md. A. Gazi, Md. R. Islam, ... Z. Mahmud in European Journal of Clinical Microbiology & Infectious Diseases
    Article 06 January 2015
Did you find what you were looking for? Share feedback.